Both cytokines have been shown in animal and human models to have anti-cancer properties: IL-2 enhances the growth and activation of natural killer cells and CD-8+ T-cells, while IFN-α enhances tumor antigen presentation, among other characteristics [28,29]. The gene discussed is CD8A; the disease is cancer.